Medications for Bone Diseases

9 results

  • cerezyme

    (IMIGLUCERASE)
    Genzyme Corporation
    Cerezyme is indicated for the treatment of adults and pediatric patients aged 2 and older with Type 1 Gaucher disease associated with anemia, thrombocytopenia, bone disease, hepatomegaly, or splenomegaly.

  • liquical with magnesium

    (Multivitamin)
    PureTek Corporation
    LiquiCal with Magnesium™ is indicated for supporting healthy bone growth and development in children.

  • sodium fluoride

    (Sodium Fluoride F 18)
    THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
    Sodium Fluoride F 18 Injection, USP is indicated for diagnostic PET imaging of bone, specifically to identify areas of altered osteogenic activity.

  • sodium fluoride

    (SODIUM FLUORIDE F-18)
    BAMF Health Inc.
    Sodium Fluoride F 18 Injection is indicated for diagnostic positron emission tomography (PET) imaging of bone, specifically to identify areas with altered osteogenic activity.

  • sodium fluoride f 18

    (sodium fluoride F 18)
    Mayo Clinic
    Sodium Fluoride F 18 Injection USP is indicated for diagnostic PET imaging of bone to identify areas of altered osteogenic activity.

  • sodium fluoride f 18

    (Sodium Fluoride F 18)
    PETNET Solutions, Inc.
    Sodium Fluoride F 18 Injection is indicated for diagnostic positron emission tomography (PET) imaging of bone, specifically to identify areas of altered osteogenic activity.

  • sodium fluoride f 18

    (SODIUM FLUORIDE F-18)
    SOFIE Co.
    Sodium Fluoride F 18 Injection, USP is indicated for diagnostic PET imaging of bone to identify areas of altered osteogenic activity.

  • sodium fluoridef 18

    (SODIUM FLUORIDE F-18)
    Children's Hospital of Michigan
    Sodium Fluoride F 18 Injection is indicated for diagnostic PET imaging of bone to identify areas of altered osteogenic activity.

  • zoledronic acid

    (zoledronic acid)
    Athenex Pharmaceutical Division, LLC.
    Zoledronic Acid Injection is indicated for treating hypercalcemia of malignancy, characterized by corrected calcium levels ≥ 12 mg/dL. It is also used for patients with multiple myeloma and bone metastases from solid tumors alongside standard cancer therapies. Safety for other hypercalcemia causes is unestablished.